Medical Information Only. Always consult your healthcare provider before enrolling in any clinical trial.
NCT00170924 · ClinicalTrials.gov registry record · Phase 4
To Find Out Whether Valsartan With or Without Other Blood Pressure Medications Would Improve the Ability of the Heart to Fill and Empty, and the Ability of the Heart Muscle to Relax Adequately in People With High Blood Pressure.
A Phase 4 study, sponsored by Novartis.
- Completed
- Registry status
- Phase 4
- Development phase
- 317
- Enrollment target
NCT00170924 is a Phase 4 study that has completed, run by Novartis. The registered enrollment target is 317 participants.
The verdict
NCT00170924, a Phase 4 study, has completed, sponsored by Novartis.
- COMPLETED
- Registry status
- Phase 4
- Development phase
- 317 participants
- Enrollment target
Study Summary
Patients who have had high blood pressure for a long time may have diastolic dysfunction. Diastolic Dysfunction is when your heart has difficulty filling and emptying, and relaxing adequately. This study is to find out if Valsartan) will improve the ability of the heart to fill, empty, and relax appropriately when given alone or with other medicines to treat high blood pressure.
Interventions
- DRUG Valsartan
Trial Details
| Field | Value |
|---|---|
| Enrollment Target | 317 participants |
| Start Date | 2004-08 |
| Est. Completion | 2006-06 |
| Phase | Phase 4 |
Interested in This Trial?
Full Details on ClinicalTrials.gov ↗What the Registry Record Tells You About NCT00170924
The ClinicalTrials.gov registry entry for NCT00170924 describes a study currently listed as completed, categorized as Phase 4. The registered enrollment target is 317 participants, a figure that helps gauge the scale of data the investigators plan to collect. The listed sponsor is Novartis, which has 265 total studies on file at ClinicalTrials.gov.
The record links to 0 conditions, and to 1 intervention - of which Valsartan is the first listed.
NCT00170924 reports 0 study locations.
Frequently Asked Questions
What is clinical trial NCT00170924 about?
NCT00170924 is a clinical study titled "To Find Out Whether Valsartan With or Without Other Blood Pressure Medications Would Improve the Ability of the Heart to Fill and Empty, and the Ability of the Heart Muscle to Relax Adequately in People With High Blood Pressure.". Patients who have had high blood pressure for a long time may have diastolic dysfunction. Diastolic Dysfunction is when your heart has difficulty filling and emptying, and relaxing adequately. This study is to find out if Valsartan) will improve the ability of the heart to fill, empty, and relax ap...
What is the current status of trial NCT00170924?
This trial is currently completed. It is a Phase 4 study. The enrollment target is 317 participants. The study started on 2004-08. Estimated completion is 2006-06.
What interventions are being tested in trial NCT00170924?
The interventions under investigation include: Valsartan (DRUG).
Who is sponsoring clinical trial NCT00170924?
This trial is sponsored by Novartis, which has 265 total clinical trials registered on ClinicalTrials.gov.
Learn More About Clinical Trials
Explore more on PlainTrial
Read our methodology - how this data is sourced, computed, and verified.
Related
Every figure on PlainTrial is rendered directly from the ClinicalTrials.gov registry, no number is typed in by an editor. This page mirrors this trial's own ClinicalTrials.gov registry record, live from the dataset. See our editorial standards & corrections policy, the methodology behind these numbers, or report a data error.